ALB and acute myeloid leukemia: Wang et al. examined the association between baseline serum ALB and overall survival (OS) in 243 AML patients (including those with primary and secondary AMLs) who received induction chemotherapy treatment; their results showed that ALB (per 1 g/L increase) were associated with a 9% increase in the OS rate (HR = 0.910, 95% CI: 0.878–0.943), and patients with an ALB level of > 35 g/L had an increasing OS rate of 65.7% compared with those ≤35 g/L (HR = 0.343, 95% CI: 0.241–0.48) [15]; The results of other studies were similar to the findings of our study [16, 17].